(VIANEWS) – Lincoln National Corporation (LNC), Royal Gold (RGLD), Vital Farms (VITL) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Lincoln National Corporation (LNC)
138.3% sales growth and 25.19% return on equity
Lincoln National Corporation, through its subsidiaries, operates multiple insurance and retirement businesses in the United States. It operates through four segments: Annuities, Retirement Plan Services, Life Insurance, and Group Protection. The Annuities segment offers variable, fixed, and indexed variable annuities. The Retirement Plan Services segment provides employers with retirement plan products and services primarily in the defined contribution retirement plan marketplace. This segment offers individual and group variable annuities, group fixed annuities, and mutual fund-based programs; and a range of plan services, including plan recordkeeping, compliance testing, participant education, and trust and custodial services. The Life Insurance segment provides life insurance products, including term insurance, such as single and survivorship versions of universal life insurance; variable universal life insurance; indexed universal life insurance products; and critical illness and long-term care riders. The Group Protection segment offers group non-medical insurance products comprising short and long-term disability, statutory disability and paid family medical leave administration and absence management services, term life, dental, vision and accident, and critical illness benefits and services to the employer marketplace through various forms of employee-paid and employer-paid plans. The company distributes its products through consultants, brokers, planners, agents, financial advisors, third-party administrators, and other intermediaries. Lincoln National Corporation was founded in 1905 and is headquartered in Radnor, Pennsylvania.
Earnings Per Share
As for profitability, Lincoln National Corporation has a trailing twelve months EPS of $9.52.
PE Ratio
Lincoln National Corporation has a trailing twelve months price to earnings ratio of 3.09. Meaning, the purchaser of the share is investing $3.09 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.19%.
Sales Growth
Lincoln National Corporation’s sales growth is negative 1.7% for the current quarter and 138.3% for the next.
Yearly Top and Bottom Value
Lincoln National Corporation’s stock is valued at $29.45 at 16:22 EST, way below its 52-week high of $36.46 and way higher than its 52-week low of $20.85.
2. Royal Gold (RGLD)
40.9% sales growth and 10.98% return on equity
Royal Gold, Inc., together with its subsidiaries, acquires and manages precious metal streams, royalties, and related interests. It focuses on acquiring stream and royalty interests or to finance projects that are in production or in development stage in exchange for stream or royalty interests, which primarily consists of gold, silver, copper, nickel, zinc, lead, and cobalt. As of June 30, 2021, the company owned interests in 187 properties on five continents, including interests on 41 producing mines and 17 development stage projects. Its stream and royalty interests on properties are located in the United States, Canada, Chile, the Dominican Republic, Australia, Africa, Mexico, and internationally. Royal Gold, Inc. was incorporated in 1981 and is headquartered in Denver, Colorado.
Earnings Per Share
As for profitability, Royal Gold has a trailing twelve months EPS of $3.64.
PE Ratio
Royal Gold has a trailing twelve months price to earnings ratio of 38.51. Meaning, the purchaser of the share is investing $38.51 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.98%.
Sales Growth
Royal Gold’s sales growth for the next quarter is 40.9%.
Previous days news about Royal Gold(RGLD)
- Royal gold rises 27% in a year: what's aiding the stock's performance?. According to Zacks on Monday, 16 September, "Solid Financial Position: Royal Gold is focused on allocating its strong cash flow to dividends, debt reduction and new businesses. "
3. Vital Farms (VITL)
15.4% sales growth and 22.73% return on equity
Vital Farms, Inc. operates as an ethical food company in the United States. It produces five pasture-raised products sourced from animals raised on small family farms, including shell eggs, butter, hard-boiled eggs, ghee, and liquid whole eggs. The company's customers include natural retailers, mainstream retailers, and foodservice partners. Vital Farms, Inc. was founded in 2007 and is headquartered in Austin, Texas.
Earnings Per Share
As for profitability, Vital Farms has a trailing twelve months EPS of $1.06.
PE Ratio
Vital Farms has a trailing twelve months price to earnings ratio of 29.65. Meaning, the purchaser of the share is investing $29.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 22.73%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 38.5%, now sitting on 541.56M for the twelve trailing months.
Previous days news about Vital Farms(VITL)
- Vital farms (vitl) outperforms broader market: what you need to know. According to Zacks on Monday, 16 September, "Market participants will be closely following the financial results of Vital Farms in its upcoming release. ", "In the latest trading session, Vital Farms (VITL Quick QuoteVITL – Free Report) closed at $31.42, marking a +0.22% move from the previous day. "
4. AppFolio (APPF)
13.6% sales growth and 41.86% return on equity
AppFolio, Inc., together with its subsidiaries, provides cloud business management solutions for the real estate industry in the United States. The company provides a cloud-based platform that enables users to automate and optimize common workflows; tools that assist with leasing, maintenance, and accounting; and other technology and services offered by third parties. It offers AppFolio Property Manager Core, a platform that provides the basic functionalities required to operate a property management business, as well as serves as a system of record; AppFolio Property Manager Plus, which offers housing management, student housing management, complex accounting, leasing insights, large-scale operations support, role-based permissions, stack integrations, and enhanced customer support services; AppFolio Property Manager Max offers customer relationship management functionality, field customization, customer database functionality, and customer success management services; and AppFolio Investment Manager, a software that provides investment management, asset management, and relationship management solutions. The company also provides value-added services that are designed to enhance, automate, and streamline processes and workflows for property management businesses, such as electronic payment, tenant screening, and insurance services. AppFolio, Inc. was incorporated in 2006 and is headquartered in Santa Barbara, California.
Earnings Per Share
As for profitability, AppFolio has a trailing twelve months EPS of $3.4.
PE Ratio
AppFolio has a trailing twelve months price to earnings ratio of 66.64. Meaning, the purchaser of the share is investing $66.64 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 41.86%.
Yearly Top and Bottom Value
AppFolio’s stock is valued at $226.59 at 16:22 EST, way below its 52-week high of $274.56 and way higher than its 52-week low of $164.29.
Moving Average
AppFolio’s worth is below its 50-day moving average of $236.35 and above its 200-day moving average of $221.05.
Growth Estimates Quarters
The company’s growth estimates for the current quarter and the next is 71.7% and 11.4%, respectively.
Sales Growth
AppFolio’s sales growth is 26.3% for the present quarter and 13.6% for the next.
5. Amphastar Pharmaceuticals (AMPH)
10.5% sales growth and 25.57% return on equity
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.
Earnings Per Share
As for profitability, Amphastar Pharmaceuticals has a trailing twelve months EPS of $3.15.
PE Ratio
Amphastar Pharmaceuticals has a trailing twelve months price to earnings ratio of 15.15. Meaning, the purchaser of the share is investing $15.15 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 25.57%.
6. Option Care Health (OPCH)
10.5% sales growth and 14.64% return on equity
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and others; infusion therapies for bleeding disorders; therapies that women need to survive and thrive through high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.
Earnings Per Share
As for profitability, Option Care Health has a trailing twelve months EPS of $1.2.
PE Ratio
Option Care Health has a trailing twelve months price to earnings ratio of 26.75. Meaning, the purchaser of the share is investing $26.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.64%.
Volume
Today’s last reported volume for Option Care Health is 1031050 which is 33.52% below its average volume of 1550950.
Moving Average
Option Care Health’s value is above its 50-day moving average of $30.27 and higher than its 200-day moving average of $30.93.
7. Bright Horizons Family Solutions (BFAM)
10% sales growth and 8.36% return on equity
Bright Horizons Family Solutions Inc. provides child care and early education services, back-up care services, educational advisory services, and other workplace solutions for employers and families. The company operates through three segments: Full Service Center-Based Child Care, Back-Up Care, and Educational Advisory and Other Services. The Full Service Center-Based Child Care segment offers traditional center-based child care and early education, preschool, and elementary education services. The Back-Up Care segment provides center-based back-up child care, in-home child and adult/elder dependent care, and self-sourced reimbursed care services. The Educational Advisory and Other Services segment offers tuition assistance and student loan repayment program administration, workforce education, and related educational consulting services, as well as college admissions advisory services. As of December 31, 2020, it operated 1,014 child care and early education centers in the United States, Puerto Rico, the United Kingdom, Canada, the Netherlands, and India. The company was formerly known as Bright Horizons Solutions Corp. and changed its name to Bright Horizons Family Solutions Inc. in July 2012. Bright Horizons Family Solutions Inc. was founded in 1986 and is headquartered in Newton, Massachusetts.
Earnings Per Share
As for profitability, Bright Horizons Family Solutions has a trailing twelve months EPS of $1.73.
PE Ratio
Bright Horizons Family Solutions has a trailing twelve months price to earnings ratio of 80.16. Meaning, the purchaser of the share is investing $80.16 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.36%.
Volume
Today’s last reported volume for Bright Horizons Family Solutions is 281660 which is 24.79% below its average volume of 374546.
Sales Growth
Bright Horizons Family Solutions’s sales growth is 15.1% for the ongoing quarter and 10% for the next.
